Risk of Ischemic Stroke Associated with Calcium Supplements and Interaction with Oral Bisphosphonates: A Nested Case-Control Study.

J Clin Med · 2023 · PMC10455805 · PMID 37629338

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

For cardioembolic IS, the AOR was 1.88 (95% CI: 1.21–2.90), with a significant trend with duration (AOR ≤1 year = 1.60; 95% CI: 0.94–2.70, and AOR >1 year = 2.73; 95% CI: 1.25–5.94; p for trend = 0.019) and no significant change with calcium daily dose (AOR Low dose (<1000 mg/d) = 2.28; 95% CI: 1.29–4.00, and AOR High dose (≥1000 mg/d) = 1.63; 95% CI: 0.70–3.81) ( Table 3 ).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.